FDA transition team
This article was originally published in The Rose Sheet
Executive Summary
Senior Associate Commissioner Linda Suydam and two agency officials will act as points of contact during transition to new Administration, FDA announces. Suydam served as special assistant to then-Deputy Commissioner for Operations Jane Henney, MD, during the 1992 transition to the Clinton Administration and returned to the agency when Henney was named commissioner in 1998. She will be joined on the 2000 transition team by Senior Associate Commissioner for Policy, Planning & Legislation William Hubbard and Executive Secretary Catherine Beck. As is customary, HHS asked FDA to prepare briefing materials for review by the new Administration. Aside from a potential new commissioner, there likely will be little change in turnover at FDA directly related to the transition